Clinical Trial: Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: This study aims to determine whether increasing atrial base rate pacing to achieve at least 75-80% atrial pacing in patients with sick sinus syndrome undergoing the implementation of dual-chamber pacemaker can be useful to prevent or decrease the atrial fibrillation during 6 months follow-up duration.
Detailed Summary:
Sponsor: Urmia University of Medical Sciences
Current Primary Outcome: Atrial high rate/Automatic mode switch episodes [ Time Frame: During 6 Months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Stroke [ Time Frame: During 6 months ]The development of stroke during follow-up
- Myocardial infarction [ Time Frame: During 6 months ]The development of MI during follow-up confirmed by ischemic chest pain, 12-ECG, or cardiac enzyme elevation
- Heart failure [ Time Frame: During 6 months ]The development or progression of heart failure during follow-up
- Worsening Functional Class [ Time Frame: During 6 months ]The worsening of functional class
- Death [ Time Frame: During 6 months ]Death
Original Secondary Outcome: Same as current
Information By: Urmia University of Medical Sciences
Dates:
Date Received: December 10, 2014
Date Started: January 2014
Date Completion:
Last Updated: October 20, 2015
Last Verified: October 2015